Jade Biosciences, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| JBIO | CLYM | DNTH | ARTV | VERA | SLDB | |
|---|---|---|---|---|---|---|
| Market cap | 890.36M | 622.03M | 4.56B | 330.99M | 2.00B | 719.48M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -5.3 | -10.8 | -17.7 | -2.6 | -6.5 | -3.9 |
| Price/book | 2.0 | 2.6 | 3.8 | 1.0 | 4.9 | 1.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +58.31% | +476.06% | +129.45% | +135.89% | −2.00% | +14.31% |
| Today | −2.71% | −1.55% | −0.97% | −2.45% | −7.23% | −2.33% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All JBIO news ›Analysts Are Bullish on Top Healthcare Stocks: Jade Biosciences (JBIO), Liquidia Technologies (LQDA)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Jade Biosciences (JBIO) and Liquidia Technologies (LQDA) with bullish sentiments. In a report released today, Matt Phipps from William Blair…
Jade Biosciences, Inc. (JBIO) Discusses JADE301 Program Profile and Preclinical Data in Dermatomyositis - Slideshow (NASDAQ:JBIO) 2026-09-30
2026-09-30. The following slide deck was published by Jade Biosciences, Inc.
From articles in the 4Search news index.
In the news
Mentioned with
Most coverage from
-
nasdaq.com1
-
seekingalpha.com1
-
theglobeandmail.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.